Company / Operating Income per Share
TherapeuticsMD, Inc. Operating Income per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.74
FY2024
5-year range
-$9.26 / $0.13
FY2020-FY2024
Trend
-689.4%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income per Share changed -689% YoY in FY2024, a notable deviation from the 9-year average annual change of -274%.
Based on SEC 10-K filings.
-0.74 in FY2024.
Improved from $-9.26 to $-0.74 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income per share decreased 689.4% year-over-year.
- Peak operating income per share was recorded in FY2023.
- Lowest operating income per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.74 | -689.4% |
| FY2023 | $0.13 | +101.4% |
| FY2022 | -$9.26 | -1734.9% |
| FY2021 | -$0.50 | -5.0% |
| FY2020 | -$0.48 | -48.7% |
| FY2019 | -$0.32 | +22.6% |
| FY2018 | -$0.42 | +3.7% |
| FY2017 | -$0.43 | -42.6% |
| FY2016 | -$0.30 | -70.6% |
| FY2015 | -$0.18 | -59.8% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026